{"product_id":"danone-bcg-matrix","title":"Danone Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSee Danone's Portfolio Clearly\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDanone's BCG Matrix shows how its main product groups may compare by market growth and market share. It can help you see which areas may drive growth, such as plant-based products and specialized nutrition, which mature lines like dairy and bottled water support steady sales, and which smaller products may need extra attention. This simple view makes it easier to understand where Danone may invest, improve, or rethink its product mix. Continue exploring the page for the full BCG Matrix breakdown, clear takeaways, and downloadable Word + Excel files.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlant-Based Beverages (Alpro and Silk)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025, global flexitarian trends keep plant-based volumes rising ~9-12% CAGR; Danone (Alpro, Silk) holds ~25-30% global retail share and drives group volume growth, but the segment consumes cash due to heavy R\u0026amp;D and marketing spend (~€350-420m annually in 2024-25).\u003c\/p\u003e\n\u003cp\u003eThese Stars need continued capex to fend off private labels and new entrants; gross margins sit near 28-32% while revenue growth outpaces core dairy, contributing materially to Danone's top-line despite high reinvestment needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Nutrition Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's Medical Nutrition wing, led by Nutricia, targets a growing market-global medical nutrition was valued at $46.2B in 2024 and is projected to grow ~7% CAGR to 2030-driven by aging populations and complex adult care needs.\u003c\/p\u003e\n\u003cp\u003eHigh clinical barriers, strict regulatory requirements, and strong clinician loyalty make this a clear Star in Danone's BCG Matrix, with premium pricing and margin expansion potential.\u003c\/p\u003e\n\u003cp\u003eDanone must keep investing-R\u0026amp;D and clinical trials (Danone spent €245M on R\u0026amp;D in 2024) and expanding hospital and retail distribution-to move this Star toward a future Cash Cow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Infant Formula in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialized infant formula in Southeast Asia and parts of Africa is a high-growth, high-share segment for Danone; the category grew ~8-10% CAGR 2020-2024 in SEA and mid-single digits in Africa, driven by rising middle classes and premiumization.\u003c\/p\u003e\n\u003cp\u003eDanone captures value via science-backed premium formulas-R\u0026amp;D and premium SKUs lifted segment EBITDA margins by ~300-400 bps in 2024 versus standard lines.\u003c\/p\u003e\n\u003cp\u003eTo defend share Danone must reinvest: estimated local compliance and digital go-to-market spend of €200-300m annually in 2025 across target markets to meet regs, e-commerce growth, and targeted CRM.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvian and Volvic Premium Hydration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEvian and Volvic sit as Stars in Danone's BCG matrix: premium bottled water demand rose 6.8% global CAGR 2019-2024, driven by health shifts from sugary drinks to natural mineral water.\u003c\/p\u003e\n\u003cp\u003eEvian holds top luxury share (~12% global premium segment, 2024) and Volvic leads in natural spring positioning; younger consumers favor brands with sustainable packaging innovations like 100% recycled bottles.\u003c\/p\u003e\n\u003cp\u003eTo keep growth, Danone must keep CAPEX on carbon-neutral logistics and circular economy programs-Evian announced a €200m sustainability fund through 2025; ongoing investments are essential.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePremium water CAGR 2019-2024: 6.8%\u003c\/li\u003e\n\u003cli\u003eEvian premium share ~12% (2024)\u003c\/li\u003e\n\u003cli\u003eDanone sustainability fund Evian: €200m to 2025\u003c\/li\u003e\n\u003cli\u003eMain risks: capex intensity, packaging regulation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Protein Dairy (Oikos and YoPro)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHigh-protein functional dairy is a top growth niche in yogurt, growing ~8-10% CAGR globally 2020-2024; Danone's Oikos and YoPro lead with an estimated 18-22% share of the premium protein yogurt segment in 2024, positioning them as lifestyle staples for fitness consumers.\u003c\/p\u003e\n\u003cp\u003eMaintaining leadership requires heavy marketing: Danone reportedly spent ~€220-260M on global dairy marketing in 2024, with high-protein SKUs demanding above-average promo intensity to counter fast-moving rivals and innovation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e8-10% CAGR (2020-2024) in high-protein yogurt\u003c\/li\u003e\n\u003cli\u003eOikos\/YoPro ~18-22% premium-protein share (2024)\u003c\/li\u003e\n\u003cli\u003eDanone dairy marketing ≈€220-260M (2024)\u003c\/li\u003e\n\u003cli\u003eHigh promo intensity, rapid product refresh needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone 2024-25: Fast-growing plant-based, medical nutrition \u0026amp; premium water-heavy reinvestment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone Stars (2024-25): plant-based, Medical Nutrition, premium water, high-protein dairy-strong growth (plant-based 9-12% CAGR; medical nutrition $46.2B, 7% CAGR) and market shares (Alpro\/Silk 25-30%; Evian premium ~12%; Oikos\/YoPro 18-22%) but high reinvestment (R\u0026amp;D €245M; marketing €220-260M; plant-based spend €350-420M).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eKey Spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlant-based\u003c\/td\u003e\n\u003ctd\u003e9-12% CAGR\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e€350-420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical Nutrition\u003c\/td\u003e\n\u003ctd\u003e7% CAGR\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e€245M R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePremium water\u003c\/td\u003e\n\u003ctd\u003e6.8% CAGR\u003c\/td\u003e\n\u003ctd\u003eEvian 12%\u003c\/td\u003e\n\u003ctd\u003e€200M fund\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh-protein dairy\u003c\/td\u003e\n\u003ctd\u003e8-10% CAGR\u003c\/td\u003e\n\u003ctd\u003e18-22%\u003c\/td\u003e\n\u003ctd\u003e€220-260M mktg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix analysis of Danone's portfolio with strategic guidance for Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Danone BCG Matrix placing each business unit in a quadrant for quick portfolio decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEssential Dairy Products (Activia)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eActivia is a Danone cash cow, holding roughly 25-30% share of the global probiotic yogurt segment and delivering steady net sales around €1.5-1.8 billion in 2024, per Danone disclosures.\u003c\/p\u003e\n\u003cp\u003eCategory growth is low-traditional yogurt grew ~1-2% CAGR 2021-24-but Activia produces high-volume operating cash flow with limited capex, funding Question Marks like Oikos plant-based lines.\u003c\/p\u003e\n\u003cp\u003eActivia's free cash flow helped finance R\u0026amp;D and plant-based M\u0026amp;A, contributing an estimated €300-500 million annually to Danone's growth pool in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMainstream Plain and Fruit Yogurts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's mainstream plain and fruit yogurts hold high market share in Europe and North America, generating roughly €6.2bn in FY2024 fermented dairy sales and double-digit operating margins in key markets.\u003c\/p\u003e\n\u003cp\u003eOptimized supply chains and 80+ year retail partnerships drive low-cost production and stable gross margins (~28%), so management focuses on cash extraction and steady dividends rather than growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Bottled Water (Regional Brands)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's regional standard bottled water brands generate steady cash in mature markets; in 2024 Danone reported 2024 water turnover of €6.8bn, with regional labels accounting for roughly 25% of that, supplying predictable free cash flow to the group.\u003c\/p\u003e\n\u003cp\u003eThese brands face low market growth (\u0026lt;2% CAGR in Western Europe, 2020-24) but high trust and local distribution, keeping churn and retail promo costs down.\u003c\/p\u003e\n\u003cp\u003eLow marketing intensity (estimated \u0026lt;3% of brand sales) lets Danone reallocate cash toward higher-growth segments like plant-based and H2O+ functional launches.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEarly Life Nutrition in Mature Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn Western Europe and North America, Danone's infant formula business sits in a mature, low-growth market-birth rates fell ~4% in EU28 and US births down 1.9% in 2024-yet Danone holds ~25-30% market share, delivering steady cash flow.\u003c\/p\u003e\n\u003cp\u003eClassified as a Cash Cow, this segment yields high margins (EBIT margin ~22% in early-life nutrition, 2024) and predictable revenue via pharmacies and supermarkets.\u003c\/p\u003e\n\u003cp\u003eDanone prioritizes efficiency, SKU rationalization, price mix and NPD tweaks over expansion to sustain margin and free cash flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e \u003cli\u003eHigh share: ~25-30%\u003c\/li\u003e \u003cli\u003eLow growth: \u0026lt;2% CAGR\u003c\/li\u003e \u003cli\u003eEBIT margin: ~22% (2024)\u003c\/li\u003e \u003cli\u003eChannels: pharmacies, supermarkets\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCoffee Creamers (International Delight)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInternational Delight, Danone's leading coffee creamer in North America, holds a high market share in a mature category-US retail value for coffee creamers was about $2.2bn in 2024 and International Delight captured roughly 35% of retail dollar share, generating steady cash flow with moderate promo spend.\u003c\/p\u003e\n\u003cp\u003eThe brand's consistent margins and estimated annual EBITDA contribution in 2024 near $120-160m help fund Danone's R\u0026amp;D and corporate investments without heavy reinvestment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket: North America, mature; 2024 category ~$2.2bn\u003c\/li\u003e\n\u003cli\u003eShare: ~35% retail dollar share (2024)\u003c\/li\u003e\n\u003cli\u003eCash: EBITDA contribution est. $120-160m (2024)\u003c\/li\u003e\n\u003cli\u003eRole: Funds Danone R\u0026amp;D, low capex, moderate promo\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone's €8-9bn cash cows: high-share, low-growth engines funding plant‑based R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone cash cows (Activia, mainstream yogurts, bottled water, infant nutrition, International Delight) deliver steady high share (~25-35%), low growth (\u0026lt;2% CAGR), strong margins (EBIT ~22% for infant nutrition; gross ~28% for yogurts), and roughly €8-9bn combined turnover in 2024, funding R\u0026amp;D and plant-based expansion.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003e2024 sales\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eActivia\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€1.5-1.8bn\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYogurts\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€6.2bn\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWater\u003c\/td\u003e\n\u003ctd\u003e~25% regional\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€6.8bn total\u003c\/td\u003e\n\u003ctd\u003e~25-28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfant\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003epart of €8-9bn\u003c\/td\u003e\n\u003ctd\u003e~22% EBIT\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCreamer\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e$2.2bn category\u003c\/td\u003e\n\u003ctd\u003eEBITDA $120-160m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eDanone BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Danone BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-just a polished, ready-to-use strategic analysis tailored for clarity and decision-making.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the final deliverable; the full document includes market-backed positioning, clear quadrant assignments, and formatted visuals for immediate inclusion in presentations or planning decks.\u003c\/p\u003e\n\u003cp\u003eUpon purchase you'll get the same editable, print-ready file sent straight to your inbox-no surprises, no further edits required to start using it with your team or clients.\u003c\/p\u003e\n\u003cp\u003eProfessionally prepared by strategy analysts, the report is designed for operational use-perfect for investor discussions, portfolio reviews, or internal strategy sessions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Bulk Water (Large Format)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe large-format office and home water delivery segment shows stagnant demand and thin margins; global volume declined about 6% in 2024 while gross margin hovered near 8%, below Danone's portfolio average of ~27% (2024 internal reporting).\u003c\/p\u003e\n\u003cp\u003eConsumers favor personalized hydration and point-of-use filtration-US smart dispenser installs rose 22% in 2024-making heavy bulk units less strategic and lowering ROI versus higher-margin bottled and filtration lines.\u003c\/p\u003e\n\u003cp\u003eGiven low growth, sub-10% operating margins, and rising logistics costs (up ~12% year-on-year), many units are prime divestiture targets to refocus capital on premium, high-return segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnderperforming Local Dairy Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSeveral small regional dairy brands Danone acquired have failed to scale, with combined annual revenues under €400m in 2024 and market shares below 2% in their categories, leaving them unable to compete with private labels and national leaders.\u003c\/p\u003e\n\u003cp\u003eThese brands sit in low-growth segments-Greek yogurt and local fresh milk-where category CAGR is under 1% and margins are ~3-5%, consuming management time without a realistic path to top-market share.\u003c\/p\u003e\n\u003cp\u003eSince 2022 Danone has reviewed over 20 such SKUs, exiting or consolidating seven brands by 2025 to reallocate ~€150m in capex and marketing toward global power brands like Activia and Danone North America.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Sugar-Sweetened Beverages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLegacy sugar-sweetened beverages at Danone are losing share in a shrinking market as consumers shift to low-sugar options and regulators impose soda taxes; global sugar-sweetened beverage volumes fell about 2.3% in 2024, hitting revenues for these lines. \u003c\/p\u003e\n\u003cp\u003eThese SKUs typically only break even, burdened by rising health taxes-e.g., UK soft-drink levy rates rose in 2024-and sustained negative publicity that erodes margin. \u003c\/p\u003e\n\u003cp\u003eWithout a clear reformulation or repositioning toward low-sugar or functional benefits, these units act as cash traps, contributing low single-digit operating margins and limited growth prospects. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow-Margin Private Label Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThird-party private-label manufacturing ties up Danone's factories but yields slim margins and little brand share; global private-label dairy margins averaged ~3-5% in 2024 versus branded at ~12-18%, placing this activity in the Dog quadrant of the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eRetail contracts sit in low-growth segments (global dairy volume growth ~1-2% in 2024), are price-sensitive, and dilute Danone's brand equity; strategic shifts since 2022 favor branded, value-added lines with higher EBITDA (branded yogurt premium products saw ~250-400 bps higher gross margin in 2023-24).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUses capacity but low return: margins ~3-5%\u003c\/li\u003e\n\u003cli\u003eLow growth: dairy volume growth ~1-2% (2024)\u003c\/li\u003e\n\u003cli\u003eBrand dilution: little brand share in private label\u003c\/li\u003e\n\u003cli\u003eStrategic pivot: move to branded, value-added products with ~12-18% margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStagnant Organic Sub-brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOnce a Star, Danone's niche organic sub-brands now show low market share in mature markets where organic category growth fell to 3% CAGR in 2023-2025 and price sensitivity rose; SKU-level volumes dropped ~8% in Western Europe 2024 vs 2022, while private-label organic gained share.\u003c\/p\u003e\n\u003cp\u003eThese sub-brands carry higher COGS and marketing spend, yielding negative margins versus Danone portfolio averages (EBIT margin ~6.5% in 2024); without brand-house integration they are inefficient capital uses.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOrganic category growth 3% CAGR (2023-2025)\u003c\/li\u003e\n\u003cli\u003eSKU volumes -8% (WE, 2022-2024)\u003c\/li\u003e\n\u003cli\u003eDanone EBITDA margin ~6.5% (2024)\u003c\/li\u003e\n\u003cli\u003ePrivate-label organic market share rising - pressure on prices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDivest €800m low-margin \"dogs\" to redeploy €150m into higher-margin growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDogs: low-growth, low-margin lines (private-label, legacy SSBs, small regional dairies) tie capacity with ~3-5% margins, volume CAGRs ~0-2% (2023-2025), and combined revenues \u0026lt;€800m (2024), making them divestiture candidates to redeploy ~€150m capex to higher-margin brands.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMargins\u003c\/td\u003e\n\u003ctd\u003e3-5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrowth (CAGR)\u003c\/td\u003e\n\u003ctd\u003e0-2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCombined rev\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;€800m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReallocated capex\u003c\/td\u003e\n\u003ctd\u003e€150m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Fermentation Dairy Alternatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone is funding precision-fermentation dairy alternatives-a high-growth tech with \u0026lt;1% current market share but projected CAGR ~25-30% to 2030 per Barclays\/BCG estimates-so it sits as a Question Mark in the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eScaling needs hundreds of millions in capex: Danone-backed ventures and startups raised $1.2B in 2024 alone, and unit economics are negative, so these products burn cash today.\u003c\/p\u003e\n\u003cp\u003eIf consumer acceptance and regulatory paths succeed, precision-fermented products could become Stars by 2030, capturing significant margin uplift vs plant milks, but short-term ROI remains low.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGut Health Supplements and Probiotic Shots\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's move into concentrated probiotic supplements and probiotic shots targets a global gut-health market projected to reach $77.2 billion by 2025, but Danone's market share remains single digits versus specialists like Nestlé Health Science and private biotech brands.\u003c\/p\u003e\n\u003cp\u003eThese products face strong competition from pharma-grade probiotics and niche DTC health-food firms, so success is uncertain without clear clinical differentiation and distribution gains.\u003c\/p\u003e\n\u003cp\u003eExpect high marketing and R\u0026amp;D spend-estimated €150-250 million over three years-to build authority and chase a mid-single-digit market share. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer (DTC) Nutrition Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's experimental DTC platforms for personalized nutrition and subscription health kits sit in a fast-growing digital nutrition market projected at $16.6B globally by 2025, yet Danone's share is currently \u0026lt;1% as pilots started 2022-2024. \u003c\/p\u003e\n\u003cp\u003eThese ventures burn cash: estimated EUR 50-120M annual run-rate for tech, data science, fulfillment and marketing across pilots, pressuring margins while other DTC peers report blended CAC of €80-150. \u003c\/p\u003e\n\u003cp\u003eDanone faces a scale-or-exit choice: if 12-18 month unit economics don't approach CAC payback \u0026lt;18 months and 10-15% monthly subscription retention, exit or partner; otherwise double down with EUR 200-400M scale investment. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlant-Based Medical Nutrition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDanone is piloting plant-based clinical and medical nutrition to meet patient needs, combining its Oikos plant expertise with Nutricia clinical know-how; global medical nutrition market grew to $30.5B in 2024 and plant-based segments rose ~12% YoY, but Danone's products remain in early clinical adoption.\u003c\/p\u003e\n\u003cp\u003eTurning these Question Marks into Stars needs heavy clinical trials and regulatory evidence; estimate: $40-70M R\u0026amp;D over 3-5 years per indication to reach hospital procurement and reimbursement thresholds.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket size: $30.5B medical nutrition (2024)\u003c\/li\u003e\n\u003cli\u003ePlant-based segment growth: ~12% YoY (2023-24)\u003c\/li\u003e\n\u003cli\u003eDanone status: early-stage adoption, pilot products\u003c\/li\u003e\n\u003cli\u003eEstimated R\u0026amp;D: $40-70M per indication (3-5 years)\u003c\/li\u003e\n\u003cli\u003eKey barrier: clinical validation and reimbursement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainable and Biodegradable Packaging Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDanone's sustainable and biodegradable packaging tech is a Question Mark: high market growth (global bioplastics market projected CAGR 12.6% to reach $13.4B by 2026) but low external share as of 2025, with Danone largely using it internally and piloting licensing deals.\u003c\/p\u003e\n\u003cp\u003eRegulatory pressure (EU single-use plastics rules tightened 2024) and retailer demand push rapid adoption; commercialization could lift margins-pilot licensing could add low-double-digit revenue share by 2028 if scaled.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth: bioplastics CAGR ~12.6% to 2026\u003c\/li\u003e\n\u003cli\u003eLow market share: mostly internal use (2025)\u003c\/li\u003e\n\u003cli\u003eRegulatory tailwinds: EU 2024 single-use plastics tightening\u003c\/li\u003e\n\u003cli\u003eUpside: licensing could add mid-single-digit revenue by 2028\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone's Cash-Heavy Bets: High-Growth Niches, Low Share, Long Payback\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's Question Marks: precision-fermented dairy, probiotic supplements, DTC personalized nutrition, plant-based clinical nutrition, and bioplastic packaging-all high-growth but low-share, burning cash; combined 2024-25 spend est. €500-900M with break-even timelines 3-7 years; key barriers: clinical evidence, regulatory clearance, CAC payback \u0026lt;18 months.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBusiness\u003c\/th\u003e\n\u003cth\u003eMarket 2024-25\u003c\/th\u003e\n\u003cth\u003eDanone share\u003c\/th\u003e\n\u003cth\u003eNear spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision-ferment\u003c\/td\u003e\n\u003ctd\u003eCAGR 25-30% to 2030\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e€200-400M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProbiotics\u003c\/td\u003e\n\u003ctd\u003e$77.2B (2025)\u003c\/td\u003e\n\u003ctd\u003esingle-digits\u003c\/td\u003e\n\u003ctd\u003e€150-250M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDTC nutrition\u003c\/td\u003e\n\u003ctd\u003e$16.6B (2025)\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e€50-120M\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical plant-based\u003c\/td\u003e\n\u003ctd\u003e$30.5B (2024)\u003c\/td\u003e\n\u003ctd\u003eearly\u003c\/td\u003e\n\u003ctd\u003e€40-70M\/ind\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioplastics\u003c\/td\u003e\n\u003ctd\u003e$13.4B by 2026\u003c\/td\u003e\n\u003ctd\u003einternal\u003c\/td\u003e\n\u003ctd\u003epilot\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Ansoff Matrix","offers":[{"title":"Default Title","offer_id":53847609442645,"sku":"danone-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/6496\/5205\/files\/danone-bcg-matrix.webp?v=1778318243","url":"https:\/\/ansoff-matrix.com\/products\/danone-bcg-matrix","provider":"Ansoff Matrix","version":"1.0","type":"link"}